Takaichi Okano

9PUBLICATIONS
49CO-AUTHORS
AutoimmunityRheumatology and arthritisPharmacogenomicsMetabolic medicineRespiratory diseases
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Jul 12, 2026
Successful salvage treatment with baricitinib for macrophage activation syndrome complicating adult-onset Still's disease during interleukin-6 inhibition: A case report and literature review.

|Jun 09, 2026
Comparative effectiveness and safety of sarilumab vs JAK inhibitors in late- and younger-onset rheumatoid arthritis.

|Mar 18, 2026
Mode of action-specific and cause-specific retention of biologic and targeted synthetic disease-modifying antirheumatic drugs in anti-SS-A antibody-positive rheumatoid arthritis: The ANSWER cohort study.

Kazuma Nishisaka, Takaichi Okano, Takumi Imai

|Jan 04, 2026
Real-world comparative effectiveness of sarilumab versus Janus kinase inhibitors as monotherapy in rheumatoid arthritis.

Yuji Nozaki, Kazuya Kishimoto, Tetsu Itami

|Jul 01, 2025
Differential Impact of Concomitant Methotrexate and Glucocorticoids Dosages on Biologics and JAK Inhibitors: The ANSWER Cohort Study.

Kosuke Ebina, Yuki Etani, Yasutaka Okita

|Mar 19, 2025
Distinct impact of RF and ACPA titre on the effectiveness and persistency of biologics and JAK inhibitors: The ANSWER cohort study.

Yuki Etani, Yasutaka Okita, Yuichi Maeda

Pageof 2

Frequent Collaborators

5 joint publications

Tadashi Okano

5 joint publications

Jun Saegusa

4 joint publications

Akira Onishi

3 joint publications

Yo Ueda